[1]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitology, Chinese Medical Association.Guidelines for prevention and treatment of hepatitis C[J].J Clin Hepatol, 2004, 12 (4) :197-203. (in Chinese) 中华医学会肝病学分会、传染病与寄生虫病学分会.丙型肝炎防治指南[J].临床肝胆病杂志, 2004, 12 (4) :197-203.
|
[2]LOU GH, LIU YN, YIN CB, et al.Preliminary study of HCV mouse model induced by infectious HCV 2a plasmid[J].J Clin Hepatol, 2011, 27 (1) :72-75. (in Chinese) 楼国华, 刘艳宁, 尹春本, 等.应用感染性丙型肝炎病毒2a质粒制备小鼠丙型肝炎模型的初步研究[J].临床肝胆病杂志, 2011, 27 (1) :72-75.
|
[3]YANG M, RAO HY.Key points of the AASLD’s guidelines on hepatitis C diagnosis and treatment[J].J Clin Hepatol, 2013, 29 (2) :9-14. (in Chinese) 杨明, 饶慧瑛.美国肝病学会丙型肝炎诊治指南要点[J].临床肝胆病杂志, 2013, 29 (2) :9-14.
|
[4]COLIN C, LANOIR D, TOUZET S, et al.Senstivity and specificity of third-generation hepatitis C virus antibody detection assay:an analysis of the literature[J].J Viral Hepat, 2001, 8 (1) :87-95.
|
[5]LI JM.Clinical enzyme immunoassay technology[M].Beijing:People's Military Medical Press, 2005:10. (in Chinese) 李金明.临床酶免疫测定技术[M].北京:人民军医出版社, 2005:10.
|
[6]KATO N.Molecular virology of hepatitis C virus[J].Acta Med Okayama, 2001, 55 (3) :133-159.
|
[7]XIE L, WU XD.Research advances in detection method for hepatitis C virus and its clinical significance[J].World Chin J Dig, 2005, 13 (7) :884-886. (in Chinese) 谢立, 吴晓东.丙型肝炎病毒检测方法的研究进展及其临床意义[J].世界华人消化杂志, 2005, 13 (7) :884-886.
|